Nov 20, 2026
United States, November 20, 2026 /MarketersMEDIA/ -- Protheragen, a specialized Contract Research Organization (CRO) dedicated to preclinical obesity research, today announced the launch of its Obesity Microbiota Research Service, an end-to-end research solution designed to examine the relationship between gut microbiota and obesity. The service encompasses animal model development, sample collection, 16S rRNA gene sequencing and/or shotgun metagenomic sequencing, and advanced bioinformatics and analytics. Leveraging research in obesity, microbiomics, and systems biology, the service focuses on identifying and prioritizing microbial targets that can aid in the development of next-generation anti-obesity therapeutics for biotechnology and pharmaceutical companies.
Research indicates that imbalances in gut microbial populations can influence the development of metabolic disorders and obesity, and ongoing work aims to elucidate the mechanisms by which these microbial populations contribute to obesity and to develop therapeutic strategies that modulate them. Protheragen's Obesity Research Platform provides biotechnology and pharmaceutical companies with an integrated system to perform preclinical research on obesity and related disorders, facilitate the identification of therapeutic targets, and support the development of personalized microbiome-modulating strategies.
The Obesity Microbiota Research Service standardizes and streamlines its processes to provide clients with reproducible data. Once an appropriate animal model (e.g., mice or rats) is selected, the service can induce obesity using various means, including dietary manipulations, environmental modifications, and genetic manipulations. After sample collection (e.g., blood, feces, and intestinal tissues), the service provides specialized processing to protect the microbial contents and increase the precision of analysis. The service uses various techniques—including 16S rRNA gene sequencing, metagenomics, and metabolomics—to characterize microbial components and their metabolites, and to elucidate their effects on host physiology. Various bioinformatics and statistical tools are used to analyze the data and draw conclusions regarding the functional capabilities of the microbial components and their roles in obesity. This service provides clients with the ability to understand functionally important microbial components and groups, identify dysbiotic microbiota associated with obesity, and support the development of microbiota-based therapies for obesity.
Beyond microbiota-focused studies, the Obesity Microbiota Research Service is part of the broader Obesity Research Platform, which supports the entire spectrum of anti-obesity therapeutic development—including small-molecule drugs that modulate the gut microbiota, gene and cell therapies, antibody therapies, tissue engineering, and other transformative approaches. Rigorous preclinical validation is conducted to provide scientific justification for advancing a therapeutic candidate to clinical trials. Each candidate undergoes pharmacodynamic and pharmacokinetic studies, toxicological evaluation, and safety assessment, with bioanalytical support provided throughout.
About Protheragen
Protheragen is a specialized Contract Research Organization (CRO) dedicated to advancing preclinical research in obesity. Driven by a passion for scientific innovation and a commitment to client success, the company has established a reputation for delivering high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics. Its integrated Obesity Research Platform seamlessly combines expertise across metabolism, inflammation, and cardiovascular biology, enabling a holistic approach to obesity research and therapy development. The company maintains quality control standards throughout its preclinical services to support the integrity and regulatory acceptance of generated data. For more information about the Obesity Microbiota Research Service, please contact Protheragen.
Contact Info:
Name: Anna White
Email: Send Email
Organization: Protheragen
Website: https://www.obesityscientific.com/
Release ID: 89210336
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
The Treasury Department is working with a private service, ID.me, to grant access to the TreasuryDirect website. Some users reported trouble getting in.
Rockstar Games ended a 13-year wait with what is expected to be the biggest entertainment launch ever.
Shares in the artificial intelligence giant jumped in their debut. But that didn’t lift the technology sector, as investors worry about the future of the A.I. boom.
A lab-grown shortcut named Leaven is wooing many high-end bakers and pizza makers who’ve prided themselves on their painstaking use of live cultures.
While Anthropic and other Silicon Valley A.I. giants are raising tens of billions in capital, Chinese rivals are struggling to keep pace financially.
China’s economy is sluggish, and its population is aging. Its people are feeling the sting of new taxes.
China’s economy is sluggish, and its population is aging. Its people are feeling the sting of new taxes.
People stocking up on long-life food drove retail sales higher October, according to official data.
Would AI be a good judge of whether you should get a mortgage, car loan or mobile phone contract?
A poker league in Fenland sees a 35% rise in players since 2022.
More than two thirds of respondents reported noticing rises in the cost of living.
The properties are marketed at premium prices with claims of “government-backed” returns, the BBC finds.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.